ICON Public Limited Company
ICLR
Κατάταξη σε μετοχές
#1647
ICON Public Limited Company, a clinical research organization, provides... ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
Τιμή μετοχής
$167.98
Τελευταίος συγχρονισμός: 2026-10-19
Κεφαλαιοποίηση
$12.96B
Αλλαγή (1 ημέρα)
-1.29%
Αλλαγή (1 έτος)
-10.86%
Χώρα
IE
Εμπόριο ICON Public Limited Company (ICLR)
Κατηγορία
Healthcare
Κέρδη για την ICON Public Limited Company (ICLR)
Κέρδη τον Jun 2026 TTM: $417.71M
Σύμφωνα με τις τελευταίες οικονομικές αναφορές της ICON Public Limited Company, τα τρέχοντα κέρδη της εταιρείας είναι $417.71M. Το 2023, η εταιρεία παρουσίασε κέρδη $624.08M, αύξηση σε σχέση με των κερδών του 2022 που ήταν $564.72M. Τα κέρδη που εμφανίζονται σε αυτή τη σελίδα είναι πριν από τόκους και φόρους, γνωστά και ως EBIT.
Ιστορικό κερδών για την ICON Public Limited Company από 2001 έως 2026
Κέρδη στο τέλος κάθε έτους
| Έτος | Κέρδη | Αλλαγή |
|---|---|---|
| 2026 (TTM) | $417.71M | -51.94% |
| 2024 | $869.18M | 39.27% |
| 2023 | $624.08M | 10.51% |
| 2022 | $564.72M | 190.31% |
| 2021 | $194.52M | -48.92% |
| 2020 | $380.84M | -10.81% |
| 2019 | $426.99M | 15.91% |
| 2018 | $368.38M | 12.42% |
| 2017 | $327.67M | 9.16% |
| 2016 | $300.17M | 7.65% |
| 2015 | $278.85M | 37.56% |
| 2014 | $202.72M | 67.72% |
| 2013 | $120.87M | 79.80% |
| 2012 | $67.22M | 131.84% |
| 2011 | $29.00M | -68.73% |
| 2010 | $92.72M | -11.42% |
| 2009 | $104.67M | 6.51% |
| 2008 | $98.28M | 36.54% |
| 2007 | $71.98M | 39.89% |
| 2006 | $51.46M | 134.06% |
| 2005 | $21.98M | -36.59% |
| 2004 | $34.67M | 37.13% |
| 2003 | $25.28M | 30.80% |
| 2002 | $19.33M | 42.18% |
| 2001 | $13.60M | 0.00% |
Κέρδη παρόμοιων εταιρειών ή ανταγωνιστών
| Εταιρεία | Κέρδη | Διαφορά Κερδών | Χώρα |
|---|---|---|---|
| $7.61B | 1,721.60% |
US
|
|
| $4.76B | 1,040.03% |
US
|
|
| $-252.70M | -160.50% |
US
|
|
| - | - |
CN
|
|
| $1.66B | 296.93% |
US
|
